Edition:
India

Indoco Remedies Ltd (INRM.NS)

INRM.NS on National Stock Exchange of India

274.45INR
19 Jan 2018
Change (% chg)

Rs7.75 (+2.91%)
Prev Close
Rs266.70
Open
Rs267.80
Day's High
Rs277.90
Day's Low
Rs267.80
Volume
103,140
Avg. Vol
152,472
52-wk High
Rs314.00
52-wk Low
Rs178.10

Chart for

About

Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company's geographical segments include India and Outside India. It offers... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

ICRA ratings for Indian debt instruments-Nov 20

Nov 20 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of November 17, 2017. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: ------------------- Aachi Spices And Foods Pvt

20 Nov 2017

BRIEF-Indoco Remedies to start production of existing ophthalmic products from Goa plant II

* Says co to start production of existing ophthalmic products from Goa plant II for U.S. market‍​ Source text - http://bit.ly/2h8Hqol Further company coverage:

07 Nov 2017

BRIEF-India's Indoco Remedies Sept-qtr profit down nearly 11 pct

* Sept quarter profit 197.6 million rupees versus profit of 221.3 million rupees last year

07 Nov 2017

BRIEF-India's Indoco Remedies says Mandar Borkar re-designated as CFO

* Says Sundeep Bambolkar, joint MD and CFO ceases to be CFO of co

10 Aug 2017

BRIEF-India's Indoco Remedies posts June-qtr loss

* June quarter loss 217.3 million rupees versus profit of 197.9 million rupees last year

09 Aug 2017

Earnings vs. Estimates

No consensus analysis data available.